Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZIM LABORATORIES Gains 10%; BSE HEALTHCARE Index Up 0.7%
Wed, 6 Nov 11:43

ZIM LABORATORIES Gains 10%; BSE HEALTHCARE Index Up 0.7%Image source: DNY59/www.istockphoto.com

ZIM LABORATORIES share price has zoomed 10% and is presently trading at Rs 118.0.

Meanwhile, the BSE HEALTHCARE index is at 44,256.3 (up 0.7%).

Among the top gainers in the BSE HEALTHCARE index today are Procter & Gamble Health (up 4.0%) and SYNGENE INTERNATIONAL (up 3.0%).

GLAND PHARMA (down 1.4%) and Abbott India (down 1.3%) are among the top losers today.

Over the last one year, ZIM LABORATORIES has moved down from Rs 122.9 to Rs 118.0, registering a loss of Rs 4.9 (down 4.0%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,089.2 to 44,256.3, registering a gain of 57.6% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 209.3%), SUVEN PHARMACEUTICALS (up 134.6%) and Glenmark Pharma (up 131.2%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 80,031.2 (up 0.7%).

The top gainers among the BSE Sensex today are HCl Tech. (up 3.6%) and TCS (up 3.5%). The most traded stocks in the BSE Sensex are ITC and Infosys.

In the meantime, NSE Nifty is at 24,381.8 (up 0.7%). TCS and HCl Tech. are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 64,958.7 to 80,031.2, registering a gain of 15,072.5 points (up 23.2%).

ZIM LABORATORIES Financial Update...

ZIM LABORATORIES net profit grew 297.3% YoY to Rs 9 million for the quarter ended June 2024, compared to a profit of Rs 2 million a year ago. Net sales rose 21.3% to Rs 818 million during the period as against Rs 674 million in April-June 2023.

For the year ended March 2024, ZIM LABORATORIES reported 29.4% decrease in net profit to Rs 172 million compared to net profit of Rs 244 million during FY23. Revenue of the company fell 7.8% to Rs 3,674 million during FY24.

The current Price to earnings ratio of ZIM LABORATORIES, based on rolling 12 month earnings, stands at 32.1.


Equitymaster requests your view! Post a comment on "ZIM LABORATORIES Gains 10%; BSE HEALTHCARE Index Up 0.7%". Click here!